Veterinary Medicines

IZOVAC ND-EDS-IBD

Suspended
  • Newcastle disease virus, strain La Sota, Inactivated
  • Eggdrop syndrome-1976 virus, strain McFerran 127, Inactivated
  • Infectious bursal disease virus, strain Winterfield 2512, Inactivated
Download as PDF

Product identification

Medicine name:
IZOVAC ND-EDS-IBD
Active substance:
  • Newcastle disease virus, strain La Sota, Inactivated
  • Eggdrop syndrome-1976 virus, strain McFerran 127, Inactivated
  • Infectious bursal disease virus, strain Winterfield 2512, Inactivated
Target species:
  • Chicken (layer hen)
  • Chicken (pullet)
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Newcastle disease virus, strain La Sota, Inactivated
    50.00
    50% Protective Dose
    /
    250.00
    millilitre(s)
  • Eggdrop syndrome-1976 virus, strain McFerran 127, Inactivated
    7.00
    log2 haemagglutination inhibiting unit(s)
    /
    250.00
    millilitre(s)
  • Infectious bursal disease virus, strain Winterfield 2512, Inactivated
    9.00
    log2 haemagglutination inhibiting unit(s)
    /
    250.00
    millilitre(s)
Pharmaceutical form:
  • Emulsion for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Chicken (layer hen)
      • Meat and offal
        30
        day
    • Chicken (pullet)
      • Meat and offal
        30
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AA09
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Suspended
Authorised in:
  • Italy
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Izo S.r.l.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Izo S.r.l.
Responsible authority:
  • Ministry Of Health
Authorisation number:
This information is not available for this product.
Date of authorisation status change:
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."